Aprea Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aprea Therapeutics

13/08/2021 05:40

* Aprea Therapeutics Inc  APRE.OQ  reported a quarterly adjusted
loss of 48 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 47 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Aprea Therapeutics Inc's reported EPS for the quarter was a
loss of 48 cents​.
* The mean earnings estimate of analysts had risen by about 3.6%
in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Aprea Therapeutics Inc shares had fallen by 17.2% this
quarter and lost 17.9% so far this year.
* The company reported a quarterly loss of $10.25 million.
* Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $5.50 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated August 13 at 04:40 a.m.  ​All
figures in US dollars unless otherwise stated